Release Date: 31/07/19 14:09 Summary: Quarterly Activity and Cashflow Statement Price Sensitive: Yes Download Document 292.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%